Logo-bi
Original Research

1. A cancer vaccine with dendritic cells differentiated with GM-CSF and IFNα and pulsed with a squaric acid treated cell lysate improves T cell priming and tumor growth control in a mouse model
Ananda Mookerjee, Michele Graciotti, Lana E. Kandalaft*
Bioimpacts. 2018;8(3): 211-221. doi: 10.15171/bi.2018.24
PMCID: PMC6128972     PMID: 30211081     Scopus ID: 85050693295    
Article
PDF
Suppl 1
Full Text
XML
Cited By:
20
8
19
Original Research

2. Chitosan nanoparticle-mediated effect of antimiRNA-324-5p on decreasing the ovarian cancer cell proliferation by regulation of GLI1 expression
Ysrafil Ysrafil* ORCID, Indwiani Astuti ORCID
BioImpacts. 2022;12(3): 195-202. doi: 10.34172/bi.2021.22119
PMCID: PMC9124874     PMID: 35677668     Scopus ID: 85132077892    
Article
PDF
Full Text
XML
Cited By:
9
1
1
Chitosan nanoparticle antimiRNA-324-5p could inhibit ovarian cancer proliferation by reduce endogenous miRNA-324-5p to lead restoration of MEN1 and generates repression of GLI1 expression.
Original Article

3. Fabrication of mesoporous silica nanoparticles for targeted delivery of sunitinib to ovarian cancer cells
Mitra Torabi ORCID, Ayuob Aghanejad*, Pouria Savadi ORCID, Abolfazl Barzegari, Yadollah Omidi ORCID, Jaleh Barar* ORCID
Bioimpacts. 2023;13(3): 255-267. doi: 10.34172/bi.2023.25298
PMCID: PMC10329750     PMID: 37431477     Scopus ID: 85158830047    
Article
PDF
Full Text
XML
Cited By:
8
0
2
Owing to their unique advantages, mesoporous silica nanoparticles (MSNPs) have attracted much attention for drug delivery and targeting. In the current study, MSNPs were fabricated, PEGylated, loaded with sunitinib, and conjugated with mucin-16 aptamer to target CA125 on ovarian cancer cells.
Original Article

4. A novel imidazo[1,2-a]pyridine derivative and its co-administration with curcumin exert anti-inflammatory effects by modulating the STAT3/NF-κB/iNOS/COX-2 signaling pathway in breast and ovarian cancer cell lines
Havva Afshari ORCID, Shokoofe Noori* ORCID, Mitra Nourbakhsh, Azam Daraei, Mahsa Azami Movahed, Afshin Zarghi
Bioimpacts. 2024;14(2): 27618. doi: 10.34172/bi.2023.27618
PMCID: PMC10945297     PMID: 38505673     Scopus ID: 85187104374    
Article
PDF
XML
Cited By:
0
0
0

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate: 24% 
Publication fee: Free of charge